Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Apellis Pharmaceuticals sell Lokrim

Start price
€18.20
07.08.23 / 20%
Target price
-
07.08.24
Performance (%)
224.18%
End price
€59.00
19.01.24
Summary
This prediction ended on 19.01.24 with a price of €59.00. The price for Apellis Pharmaceuticals massively increased, which is bad news for the SELL prediction by Lokrim. Lokrim has 20% into this prediction
Performance without dividends (%)
Name 1w 1m
Apellis Pharmaceuticals - -
iShares Core DAX® 2.831% 1.236%
iShares Nasdaq 100 2.918% 0.640%
iShares Nikkei 225® 2.007% -2.135%
iShares S&P 500 2.257% 0.451%

According to Lokrim what are the pros and cons of Apellis Pharmaceuticals for the foreseeable future?

Pros
Cons
Probably not worthwhile Investment

Comments by Lokrim for this prediction

In the thread Apellis Pharmaceuticals diskutieren

Sell Apellis Pharmaceuticals

In the thread Trading Apellis Pharmaceuticals
Prediction Sell
Perf. (%) 224.18%
Target price
Change
Ends at 07.08.24

Sell beendet